SH-RegistrySafety and Performance of Abbott Structural Heart Devices
Data Collection
Congenital Abnormalities+7
+ Cardiovascular Diseases
+ Heart Defects, Congenital
Cohort
Tracking disease incidence in order to identify risk factors and understand disease progression over time.Summary
Study start date: August 21, 2024
Actual date on which the first participant was enrolled.The Abbott Structural Heart Device Registry is a study focused on understanding how well Abbott's heart devices perform and how safe they are when used in everyday hospital settings. This study involves patients who are receiving these devices as part of their standard medical care. It aims to include around 500 participants each year over a minimum of five years. This research is critical because it helps ensure that these devices, used in heart procedures, work effectively and safely for patients around the world. By doing so, the study aims to improve heart treatment options and outcomes for patients who need these devices. Participants in this study will have their data collected after they consent and undergo a procedure involving an Abbott heart device. The study tracks how well the procedures go by measuring the number of successful device implants and monitors potential safety concerns by noting any serious health issues related to the device or procedure within a week afterward. Follow-up visits are scheduled based on the type of device used, ranging from a few months to up to ten years in some cases. These visits can happen in person, over the phone, or virtually, depending on what is standard for the patient's hospital. Additionally, data from European sites are collected to support approval for specific heart valve sizes in the U.S.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.2500 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Cohort
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 27 locations
Tartu University Hospital
Tartu, EstoniaCHRU Hopital de Pontchaillou
Rennes, FranceCentre Médico Chirurgical Marie Lannelongue
Le Plessis-Robinson, France